These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7618941)

  • 1. Increased generation of cysteinyl leukotrienes in Kawasaki disease.
    Mayatepek E; Lehmann WD
    Arch Dis Child; 1995 Jun; 72(6):526-7. PubMed ID: 7618941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased excretion of endogenous urinary leukotriene E4 in extrahepatic cholestasis.
    Mayatepek E; Pecher G
    Clin Chim Acta; 1993 Sep; 218(2):185-92. PubMed ID: 8306442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteinyl leukotrienes in the urine of patients with liver diseases.
    Uemura M; Buchholz U; Kojima H; Keppler A; Hafkemeyer P; Fukui H; Tsujii T; Keppler D
    Hepatology; 1994 Oct; 20(4 Pt 1):804-12. PubMed ID: 7927219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced synthesis of cysteinyl leukotrienes in juvenile rheumatoid arthritis.
    Fauler J; Thon A; Tsikas D; von der Hardt H; Frölich JC
    Arthritis Rheum; 1994 Jan; 37(1):93-7. PubMed ID: 8129769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased urinary leukotriene E4 excretion in patients with atopic dermatitis.
    Hishinuma T; Suzuki N; Aiba S; Tagami H; Mizugaki M
    Br J Dermatol; 2001 Jan; 144(1):19-23. PubMed ID: 11167678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased urinary leukotriene E(4) during febrile attacks in the hyperimmunoglobulinaemia D and periodic fever syndrome.
    Frenkel J; Willemsen MA; Weemaes CM; Dorland L; Mayatepek E
    Arch Dis Child; 2001 Aug; 85(2):158-9. PubMed ID: 11466192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of cysteinyl leukotriene synthesis in man.
    Frölich JC; Fauler J; Tsikas D
    J Lipid Mediat Cell Signal; 1994 Feb; 9(1):75-8. PubMed ID: 8032717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of urinary leukotriene E4 in children with severe atopic eczema/dermatitis syndrome.
    Øymar K; Aksnes L
    Allergy; 2005 Jan; 60(1):86-9. PubMed ID: 15575936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gas chromatographic-mass spectrometric determination of leukotriene E4 in human urine using deuterium-labelled leukotriene E4 standards.
    Tsikas D; Fauler J; Gutzki FM; Röder T; Bestmann HJ; Frölich JC
    J Chromatogr; 1993 Dec; 622(1):1-7. PubMed ID: 8120106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced synthesis of cysteinyl leukotrienes in psoriasis.
    Fauler J; Neumann C; Tsikas D; Frölich J
    J Invest Dermatol; 1992 Jul; 99(1):8-11. PubMed ID: 1318908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective hepatobiliary leukotriene elimination in patients with the Dubin-Johnson syndrome.
    Mayatepek E; Lehmann WD
    Clin Chim Acta; 1996 May; 249(1-2):37-46. PubMed ID: 8737590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotrienes in the pathophysiology of kwashiorkor.
    Mayatepek E; Becker K; Gana L; Hoffmann GF; Leichsenring M
    Lancet; 1993 Oct; 342(8877):958-60. PubMed ID: 8105215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical synthesis of dioxygen-18 labelled omega-/beta-oxidized cysteinyl leukotrienes: analysis by gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry.
    Tsikas D; Fauler J; Frölich JC
    J Chromatogr B Biomed Appl; 1995 May; 667(2):209-21. PubMed ID: 7663693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced synthesis of cysteinyl leukotrienes in atopic dermatitis.
    Fauler J; Neumann C; Tsikas D; Frölich J
    Br J Dermatol; 1993 Jun; 128(6):627-30. PubMed ID: 8393333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficient synthesis of cysteinyl leukotrienes in glutathione synthetase deficiency.
    Mayatepek E; Becker K; Carlsson B; Larsson A; Hoffmann GF
    Int J Tissue React; 1993; 15(6):245-52. PubMed ID: 8088946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical and clinical validation of an LC-MS/MS method for urine leukotriene E4: A marker of systemic mastocytosis.
    Lueke AJ; Meeusen JW; Donato LJ; Gray AV; Butterfield JH; Saenger AK
    Clin Biochem; 2016 Sep; 49(13-14):979-82. PubMed ID: 26908217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced excretion of urinary leukotriene E4 in coronary artery disease and after coronary artery bypass surgery.
    Allen SP; Sampson AP; Piper PJ; Chester AH; Ohri SK; Yacoub MH
    Coron Artery Dis; 1993 Oct; 4(10):899-904. PubMed ID: 8269196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced urinary excretion of cysteinyl leukotrienes in patients with acute alcohol intoxication.
    Uemura M; Lehmann WD; Schneider W; Seitz HK; Benner A; Keppler-Hafkemeyer A; Hafkemeyer P; Kojima H; Fujimoto M; Tsujii T; Fukui H; Keppler D
    Gastroenterology; 2000 Jun; 118(6):1140-8. PubMed ID: 10833489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference in urinary 11-dehydro TXB2 and LTE4 excretion in patients with rheumatoid arthritis.
    Nakamura H; Hishinuma T; Suzuki N; Chiba S; Tsukamoto H; Takabatake M; Sawai T; Mitomo T; Inoue H; Matsumoto F; Mizugaki M
    Prostaglandins Leukot Essent Fatty Acids; 2001; 65(5-6):301-6. PubMed ID: 11993724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteinyl leukotriene involvement in chronic lung disease in premature infants.
    Cook AJ; Yuksel B; Sampson AP; Greenough A; Price JF
    Eur Respir J; 1996 Sep; 9(9):1907-12. PubMed ID: 8880111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.